Effect of antisense oligomer in controlling c-raf.1 overexpression during diethylnitrosamine-induced hepatocarcinogenesis in rat

Cancer Chemotherapy and Pharmacology

Volumn 65, Issue 2, 2010, Pages 309-318

  Das, Tanushree ^a   Patra, Falguni ^a   Mukherjee, Biswajit ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

C raf.1; Hepatocarcinogenesis; Hyperplastic nodule; In situ hybridization; Marker enzymes

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYTOCHROME P450; DIETHYLNITROSAMINE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; MESSENGER RNA; OLIGONUCLEOTIDE PHOSPHOROTHIOATE; RAF PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTISENSE THERAPY; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; GENE OVEREXPRESSION; LIPID PEROXIDATION; LIVER CARCINOGENESIS; LIVER CARCINOMA; LIVER CELL CARCINOMA; LIVER HYPERPLASIA; LIVER NODULE; LIVER STRUCTURE; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 ENZYME SYSTEM; DIETHYLNITROSAMINE; HYPERPLASIA; LIPID PEROXIDATION; LIVER NEOPLASMS; MALE; OLIGONUCLEOTIDES, ANTISENSE; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-RAF; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 71349086618     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1035-4     Document Type: Article

References (60)

1. E Farber 1991 Hepatocyte proliferation in stepwise development of experimental liver cell cancer Dig Dis Sci 36 973 978 10.1007/BF01297150 2070708
2. Pitot HC (1986) Fundamentals of oncology, 3rd edn. Mercel Dekker, New York, p 532
3. HC Pitot AE Sirica 1980 The stages of initiation and promotion in hepatocarcinogenesis Biochem Biophys Acta 605 191 215 6249365
4. R Schulte-Hermann 1985 Tumor promotion in the liver Arch Toxicol 57 147 185 10.1007/BF00290879 3904674 (Pubitemid 16248357)
5. HC Pitot YP Dragan 1991 Facts and theories concerning the mechanisms of carcinogenesis FASEB J 5 2280 2286 1860619
6. JE Klaunig LM Kamendulis 1999 Mechanism of cancer chemoprevention in hepatic carcinogenesis: modulation of focal lesion growth in mice Toxicol Sci 52 101 106 10630597
7. P Bannasch 1984 Sequential cellular changes during chemical carcinogenesis J Cancer Res Clin Oncol 108 11 22 10.1007/BF00390968 6746700
8. R Schulte-Hermann 1987 Initiation and promotion in hepatocarcinogenesis Arch Toxicol 60 179 181 10.1007/BF00296976 3304207 (Pubitemid 17081713)
9. R Schulte-Hermann W Bursch B Grasl-Kraupp, et al. 1995 Role of active cell death (apoptosis) in multi-stage carcinogenesis Toxicol Lett 82 143 148 10.1016/0378-4274(95)03550-8 8597042 (Pubitemid 26054700)
10. E Farber DS Sarma 1987 Hepatocarcinogenesis: a dynamic cellular perspective Lab Invest 56 1 4 22 3025514
11. HM Rabes 1983 Development and growth of early preneoplastic lesions induced in the liver by chemical carcinogen J Cancer Res Clin Oncol 106 85 92 10.1007/BF00395384 6630286
12. WB Coleman 2003 Mechanisms of human hepatocarcinogenesis Curr Mol Med 3 6 573 588 10.2174/1566524033479546 14527088 (Pubitemid 37168599)
13. KL Kolaja DE Stevenson EF Walborg Jr, et al. 1996 Reversibility of promoter induced hepatic focal lesion growth in mice Carcinogenesis 17 7 1403 1409 10.1093/carcin/17.7.1403 8706241 (Pubitemid 26242643)
14. P Bannasch 1968 The cytoplasm of hepatocytes during carcinogenesis Recent Results Cancer Res 19 1 100
15. P Bannasch D Mayer HJ Hacker 1980 Hepatocellular glycogenosis and hepatocarcinogenesis Biochim Biophys Acta 605 217 245 6994813
16. P Bannasch HJ Hacker F Klimek, et al. 1984 Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis Adv Enzym Reg 22 97 121 10.1016/0065-2571(84)90010-4
17. MW Roomi RK Ho DSR Sarma, et al. 1985 A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat Cancer Res 45 564 571 2857108
18. A Buchmann M Schwarz R Schmitt, et al. 1987 Development of cytochrome P-450-altered preneoplastic and neoplastic lesions during nitrosamine-induced hepatocarcinogenesis in the rat Cancer Res 47 2911 2918 3567909 (Pubitemid 17113435)
19. R Lindahl R Feinstein 1876 Purification and characterization of aldehyde dehydrogenase from 2-acetylaminofluorene induced rat hepatomas Biochim Biophys Acta 452 345 355
20. W Levin AYH Lu PE Thomas, et al. 1978 Identification of epoxide hydrolase in rat liver hyperplastic nodules Proc Natl Acad Sci USA 75 3240 3243 10.1073/pnas.75.7.3240 210455
21. K Satoh A Kitahara Y Soma, et al. 1985 Purification, induction and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in rat chemical hepatocarcinogenesis Proc Natl Acad Sci USA 85 3964 3968 10.1073/pnas.82.12.3964 (Pubitemid 15052809)
22. Y Sánchez-Pérez C Carrasco-Legleu C García-Cuellar, et al. 2005 Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis Cancer Lett 217 1 25 32 10.1016/j.canlet.2004.07.019 15596293 (Pubitemid 39642863)
23. G Daum I Eisenmann-Tappe HW Fries, et al. 1994 The ins and outs of Raf kinases Trends Biochem Sci 19 474 480 10.1016/0968-0004(94)90133-3 7855890 (Pubitemid 24342760)
24. UR Rapp 1991 Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction Oncogene 6 495 500 2030909
25. J Sebolt-Leopold 2000 Development of anticancer drugs targeting the MAP kinase pathway Oncogene 19 6594 6599 10.1038/sj.onc.1204083 11426644 (Pubitemid 32197697)
26. J Avruch A Khokhlatchev JM Kyriakis, et al. 2001 Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade Recent Prog Horm Res 56 127 155 10.1210/rp.56.1.127 11237210 (Pubitemid 36068058)
27. SM Störm UR Rapp 1993 Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors Toxicol Lett 67 201 210 10.1016/0378-4274(93)90056-4 8451761 (Pubitemid 223051334)
28. VP Stanton Jr GM Cooper 1987 Activation of human raf transforming genes by deletion of normal amino-terminal coding sequences Mol Cell Biol 7 1171 1179 3561413
29. SM Störm U Brennscheidt G Sithanandam, et al. 1990 Raf oncogenes in carcinogenesis Crit Rev Oncog 2 1 8 2091747
30. ST Crooke 1993 Therapeutic application of oligonucleotides Annu Rev Pharmacol Toxicol 32 329 376 10.1146/annurev.pa.32.040192.001553
31. ST Crooke 1999 Molecular mechanisms of action of antisense drugs Biochim Biophys Acta 1489 31 44 10806995
32. HC Pitot C Peraino PA Morse Jr VR Potter 1964 Hepatomas in tissue culture compared with adapting liver in vivo Natl Cancer Inst Monogr 13 229 245 14143233
33. MD Reuber 1961 A transplantable bile-secreting hepatocellular carcinoma in the rat J Natl Cancer Inst 26 891 897 13740982
34. B Mukherjee M Basu M Chatterjee 2001 Effect of selenomethionine on n-methylnitrosoguanidine-induced colonic aberrant crypt foci in rats Eur J Cancer Prev 10 347 355 10.1097/00008469-200108000-00008 11535877 (Pubitemid 32735351)
35. FS Moreno MB Rizzi ML Dagli, et al. 1991 Inhibitory effects of β-carotene on preneoplastic lesions induced in Wistar rats by the resistant hepatocyte model Carcinogenesis 12 10 1817 1822 10.1093/carcin/12.10.1817 1934263
36. P Bannasch 1976 Cytology and cytogenesis of neoplastic (hyperplastic) hepatic nodules Cancer Res 367 2555 2562
37. P Bannasch UR Jahn HJ Hacker, et al. 1997 Focal hepatic glycogenosis: a putative preneoplastic lesion associated with neoplasia and cirrhosis in explanted human livers Int J Oncol 10 261 268
38. D Yang E Alt CE Rogler 1993 Coordinate expression of N-myc2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers Cancer Res 53 2020 2027 8481904
39. B Mukherjee S Ghosh T Das, et al. 2005 Characterization of insulin-like-growth factor II (IGF II) mRNA positive hepatic altered foci and IGF II expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats J Carcinogenesis 4 12 10.1186/1477-3163-4-12 (Pubitemid 41461123)
40. T Omura N Sato 1964 The carbon monoxide-binding pigment of liver microsome J Biol Chem 239 2370 2378 14209971
41. WH Habig MI Pabst WB Jacob 1975 Glutathione S-transferase: the first enzymatic step in mercapturic acid formation J Biol Chem 249 7130 7139
42. T Anderson M Pesonens C Johansson 1985 Differentiatial induction of cytochrome P-450 dependent monoxygenase, epoxide hydrolase, glutathione transferase and UDP-glucuronosyl transferase activities in the liver of the rainbow trout by β-napthoflavone or clophen A 50 Biol Chem Pharmacol 34 3309 3314
43. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with the Folin-phenol reagent J Biol Chem 193 265 275 14907713
44. WG Nichans B Samuelson 1968 Formation of MDA from phospholipid arachidonate during microsomal lipid peroxidation Eur J Biochem 6 126 130 10.1111/j.1432-1033.1968.tb00428.x
45. O Braissant W Wahli 1998 A simplified in situ hybridization protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections Biochemica 1 10 16
46. HG Jasper A Brasel 1980 Rat liver DNA synthesis during the "Catch-up" growth of varied nutritional rehabilitation J Nutr 110 2336 2340 7441364
47. WH Jeffrey JH Paul 1988 Underestimation of DNA synthesis by [3H] thymidine incorporation in marine bacteria Appl Environ Microbiol 54 12 3165 3168 16347806
48. Q Su A Benner WJ Hofmann, et al. 1997 Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia Virchows Arch 431 6 391 406 10.1007/s004280050116 9428927 (Pubitemid 27519372)
49. H Esterbauer RJ Schaur H Zollner 1991 Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes Free Radic Biol Med 11 81 128 10.1016/0891-5849(91)90192-6 1937131
50. CE Vaca J Wilhelm M Harms-Ringdahl 1988 Interaction of lipid peroxidation products with DNA. A review Mutat Res 195 137 149 3277035
51. C Ji CA Rouzer LJ Marnett, et al. 1998 Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde Carcinogenesis 19 7 1275 1283 10.1093/carcin/19.7.1275 9683189 (Pubitemid 28375380)
52. DL Barnard E Hettich XF Chuang, et al. 1995 Identification of the sites of interaction between c-raf.1 and Ras-GTP Oncogene 10 1283 1290 7731678
53. PB Watkins 1992 Drug metabolism by cytochromes P450 in the liver and small bowel Gastroenterol Clin North Am 21 511 526 1516957
54. Dahm LJ, Jones DP (1996) Mechanisms of chemically induced liver disease. In: Zakin D, Boyer TD (eds) Hepatology: a textbook of liver disease, 3rd edn. Saunders, Philadelphia, pp 875-890
55. WM Lee 1995 Drug-induced hepatotoxicity N Engl J Med 333 1118 1127 10.1056/NEJM199510263331706 7565951
56. KW Bock W Lilienblum H Pfeil, et al. 1982 Increased uridine diphosphate-glucuronyltransferase activity in preneoplastic liver nodules and Morris hepatomas Cancer Res 42 3747 3752 6179609
57. M Tatematsu Y Mera N Ito, et al. 1985 Relative merits of immunohistochemical demonstrations of placenta, A, B and C forms of glutathione S-transferase and histochemical demonstration of f-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats Carcinogenesis 6 1621 1626 10.1093/carcin/6.11.1621 2865013
58. Bannasch P (1996) Pathogenesis of hepatocellular cacinoma: sequential cellular, molecular, and metabolic changes. In: Boyer JL, Ockner RK (eds) Progress in liver diseases, vol 14. Saunders, Philadelphia, pp 161-197
59. Y Hwang J Choi S Kim, et al. 2004 Over-expression of c-raf-1 protooncogene in liver cirrhosis and hepatocellular carcinoma Hepatology Res. 29 113 121 10.1016/j.hepres.2004.02.009 (Pubitemid 38667508)
60. DG Beer MJ Neveu DL Paul, et al. 1988 Expression of the c-mf protooncogene, 7-glutamyltranspeptidase, and gap junction protein in rat liver neoplasms Cancer Res 48 1610 1617 2894242